• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,100.47 109.25
( 0.14%)
Global Indices
Nasdaq
51,823.54 -118.08
(-0.23%)
Dow Jones
7,358.68 -19.81
(-0.27%)
Hang Seng
69,065.93 -3,300.41
(-4.56%)
Nikkei 225
10,515.14 -14.75
(-0.14%)
Forex
USD-INR
94.41 -0.14
(-0.15%)
EUR-INR
107.28 -0.07
(-0.07%)
GBP-INR
124.48 -0.08
(-0.06%)
JPY-INR
0.58 0.00
(-0.20%)

EQUITY - MARKET SCREENER

Lupin Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500257
INE326A01037
659.0470742
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
LUPIN
17.76
107090.72
EPS(TTM)
Face Value()
Div & Yield %
131.91
2
0.77
 

As on: Jun 25, 2026 12:00 AM

Last Price() Net Change (%) Volume (Nos) P / E
2,342.15 -25.65 18125 17.76
Stock Price Details
Open Price() 2,379.95
Best Buy () 0
Best Sell () 0
Buy Quantity (Nos) 0
Sell Quantity (Nos) 0
Today's High () 2,389.90
Today's Low () 2,336.90
52-Week High () 2492
152-Week Low () 1838.65
CHART
  • |
  • |
  • |
  • |
Market Statistics
Div & Yield % 0.77
Eps 131.91
Book Value 659.0470742
Market Cap (.Cr) 107,090.72
Face Value 2
Market Lot 1
AGM Date Aug
Book Closure Date
ISIN No. INE326A01037


News
Lupin receives USFDA tentative approval for Enzalutamide Tablets
Lupin gets USFDA tentative nod for generic Xtandi tablets
Indices trade sideways in early trade; breadth strong
Lupin gains after launching generic hypertension drug in the US
Lupin launches generic hypertension drug in the US
Lupin partners with Spain’s ERN for launch of asthma, COPD inhaler Luforbec
Lupin launches Luforbec® inhaler in Spain
Lupin gains after receiving USFDA nod for Ranluspec
Lupin and alliance partner Natco receive USFDA approval for Eribulin Mesylate Injection
Lupin receives Establishment Inspection Report for its Ankleshwar unit
More
Corporate Details
Incoporation Year   : 1983
Chairman : M D Gupta
Bussiness Group : Indian Private
Registered Office
Lupin Ltd
Kalpataru Inspire 3rd Floor,
Off Western Exp HW Santacruz-E,
Mumbai,
Maharashtra-400055
Cement House,
121 Maharshi Karve Road,
Mumbai,
Maharashtra-400020
Phone:91-22-6640 2323
Fax:91-22-6640 8131
Fax:91-22-66317458
E-Mail : investorservices@lupinpharma.com
URL : https://www.lupin.com/


Exchange Information
Bombay Stock Exchange National Stock Exchange Other Listed Exchanges
  • BSE 100
  • BSE 500
  • BSE 200
  • BSE HC
  • BSE DOLLEX
  • BSE Shariah 50
  • CNX 500
  • Nifty Midcap50
  • CNX Midcap
  • CNX Pharma
  • CNX 200
  • BSE
  • Kolkata
  • Chennai
  • Ahmedabad
  • Delhi
  • Kochi